Skip to content

NoRCoRP Assessment Clinic

The Nottingham Recovery From COVID-19 Research Platform Assessment Clinic

Status
Completed
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04710836
Acronym
NoRCoRP
Enrollment
254
Registered
2021-01-15
Start date
2020-12-03
Completion date
2024-08-08
Last updated
2025-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Covid19

Brief summary

The main overarching aim of this study is to build a research clinic, as part of the NoRCoRP platform covering Nottingham and Nottinghamshire to facilitate learning and research in the whole population of patients who have had COVID-19.

Detailed description

The severe acute respiratory syndrome-coronavirus-2 (SARS-CoV-2 / COVID-19) pandemic, has affected over 13 million people, and caused significant worldwide mortality and morbidity. Frequent long-term respiratory complications include persistent breathlessness and fatigue, with potential for ongoing organising pneumonia and new pulmonary fibrosis as well as thromboembolic disease. Additional features seen in at least some patients post hospital include impaired musculoskeletal function, impaired renal function, neurological impairment, cardiac dysfunction and significant psychiatric morbidity. The majority of patients with COVID-19 were not admitted to hospital, and the longer-term consequences of infection with SARS-CoV-2 in this much larger patient group are unknown. Whilst many patients had relatively mild disease and made a good recovery, a significant number have been left with symptoms similar to those who were admitted to hospital. In setting up a post COVID-19 respiratory review clinic, we expect to generate new findings, support studies that have already been submitted for funding, to provide a focus for further grant funding, and to provide an infrastructure to support new clinical trials. We also expect the insights gained from research using this platform to be of value for service planning in the region and beyond. We will prioritise patients who were not admitted to hospital but who have been left with significant morbidity by establishing this new General Practitioner (GP) referral research clinic.

Interventions

None listed

Sponsors

Nottingham University Hospitals NHS Trust
Lead SponsorOTHER

Study design

Observational model
COHORT
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Adults (≥18 years) referred into the post COVID-19 respiratory outpatient clinic from primary care, following a swab, imaging or strong clinical diagnosis of COVID-19 * Adults discharged from hospital with a clinical diagnosis of COVID-19 (who are not included in the PHOSP-COVID study)

Exclusion criteria

* Children (\<18 years) referred into the post COVID-19 respiratory outpatient clinic. This clinic is only open to adults and referrals for children will not be accepted * Adults discharged from hospital with a clinical diagnosis of COVID-19 and have been included in the PHOSP-COVID study * Patients unable to provide informed consent by themselves

Design outcomes

Primary

MeasureTime frameDescription
Montreal Cognitive AssessmentSeptember 2020 - August 2024Assessment of cognitive state using the MoCA questionnaire
Number of participants with symptoms at presentation to the research clinicSeptember 2020 - August 2024Patient reported symptoms
Short Physical Performance BatterySeptember 2020 - August 2024Assessment of functional capacity
Quadricep muscle strengthSeptember 2020 - August 2024Assessment of functional capacity using a handheld dynamometer
Chalder's Fatigue ScoreSeptember 2020 - August 2024Assessment of fatigue using the Chalder 11-item fatigue questionnaire
Number of participants with rehabilitation needs at presentation to clinicSeptember 2020 - August 2024Rehabilitation needs based on clinical assessment by a multidisciplinary team (musculoskeletal, cognitive and cardiopulmonary)
EQ-5D-5LSeptember 2020 - August 2024Assessment of generic health status using the EQ-5D-5L questionnaire

Secondary

MeasureTime frameDescription
Pittsburgh Sleep Quality IndexSeptember 2020 - August 2024Assessment of sleep quality using the PSQI questionnaire
Healthcare service needs following COVID-19 diagnosisSeptember 2020 - August 2032Monitoring of NHS records for incidence of re-presentation to primary or secondary care related to COVID-19 complications and survival.
Biological markers of recovery from COVID-19September 2020 - August 2032Assessment of blood taken for clinical purposes (where available) including renal function, liver function, full blood count, HbA1C, Brain natriuretic peptide, vitamin D, thyroid function, C-reactive protein (CRP), Creatine kinase for markers of COVID-19 recovery. Batched inflammatory and metabolic markers as well as whole blood DNA will also be assessed from stored samples.
Fried Frailty IndexSeptember 2020 - August 2024Frailty assessment covering: shrinking, exhaustion, physical activity, slowness and weakness domains.
Body compositionSeptember 2020 - August 2024Body composition derived from bioelectrical impedance analysis to determine: body mass index, fat free mass index, fat free mass (kg), fat mass (kg).
Anxiety and DepressionSeptember 2020 - August 2024Derived by completion of the Hospital Anxiety and Depression Scale (HADS) questionnaire

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026